ask="25.30"
ask_size="100"
average_daily_volume="42584"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-0.05"
change_from_200_day_moving_average="-0.39"
change_from_50_day_moving_average="-3.10"
change_from_52_week_high="-7.44"
change_From_52_week_low="8.90"
change_in_percent="-0.26%"
close="18.92"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.14"
ex_dividend_date="N/A"
float_shares="6898000"
high="19.82"
high_52_weeks="26.36"
last_trade_date="1/18/2017"
last_trade_price="18.92"
last_trade_size="325"
last_trade_time="4:00pm"
low="18.66"
low_52_weeks="10.02"
market_capitalization="316.23M"
moving_average_200_day="19.31"
moving_average_50_day="22.02"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="19.82"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.04%"
percent_change_from_50_day_moving_average="-14.09%"
percent_change_from_52_week_high="-28.22%"
percent_change_from_52_week_low="+88.82%"
previous_close="18.97"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.25"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.09"
stock_exchange="NGM"
symbol="PTGX"
volume="11258"
weeks_range_52="10.02 - 26.36"
